| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |